Wall Street Journal -- Boston Scientific Corp. (BSX), which is dealing with sluggish conditions in top heart-device markets, is conducting “focused workforce reductions” as it continues ongoing restructuring and cost-cutting efforts and deals with sluggish conditions in top markets, a spokesman confirmed Wednesday. The Natick, Mass., company declined to offer specifics on the job cuts and was unable to immediately say whether they add to, or are part of, reductions announced last year.
